Non-Invasive Imaging Biomarker Identifies Small Airway Damage in Severe COPD.

CONCLUSION: PRMfSAD identifies areas of lung tissue with TB loss, luminal narrowing, and obstruction. This is first confirmation that an imaging biomarker can identify terminal bronchial pathology in established COPD and provides a non-invasive imaging methodology to identify small airway damage in COPD. PMID: 30794432 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30794432?dopt=Abstract

Source: American Journal of Respiratory and Critical Care Medicine - February 22, 2019 Category: Respiratory Medicine Authors: Vasilescu DM, Martinez FJ, Marchetti N, Galbán CJ, Hatt C, Meldrum CA, Dass C, Tanabe N, Reddy RM, Lagstein A, Ross BD, Labaki WW, Murray S, Xia M, Curtis JL, Hackett TL, Kazerooni EA, Criner GJ, Hogg JC, Han MK Tags: Am J Respir Crit Care Med Source Type: research